The company microDimensions was founded as a spin-off of the Technische Universität München in 2011. As a provider of software solutions for the processing, visualization, and analysis of microscopic image data the company aims to speed up work-flows for pharmaceutical and biotech companies as well as researchers in the field of digital pathology.

microDimensions’ first product Voloom®, released in 2012, gained lots of attention in the market as it is the first solution for the reconstruction of consecutive histology sections stored as virtual slides. In December 2013, microDimensions closed a financing round with three investment partners (HTGF, Bayernkapital, and a private investor). The fresh capital is used to intensify research and development for future products.

Within the last years, the company has established a strong partner network in the field of digital slide scanning and microscopic software manufacturers, amongst them the European market leader for digital slide scanners, 3DHISTECH, Hungary, and the market leader for multi-dimensional microscopic image analysis, Bitplane AG, Switzerland.


microDimensions produces innovative software solutions for the processing, analysis, and visualization of biomedical imagery, in particular on a cellular level. Employees of microDimensions continuously strive to create efficient algorithms fulfilling highest quality standards. A particular focus of the company is to offer digital pathology software that can be integrated into the existing customer workflow seamlessly.

Customers of microDimensions are pathologists and image analysts working with whole slide imaging devices for medical research and patient diagnosis. With the products of microDimensions our customers are able to create new information extracted from existing images and speed up the laboratory or diagnostic workflow through increased automation.


Our team has a combined 35+ years of experience in the development of sophisticated technologies and software for computer aided diagnosis and interventions. Thanks to our close collaboration with national and international universities, microDimensions has established a biomedical network and partnerships with manufacturers of medical technology and the pharmaceutical industry.

Technical expertise in combination with a strong network of partners and collaborators leverages the success of products developed by microDimensions.


Martin Groher

Dr. Martin Groher (CEO)
is co-founder of microDimensions. He received his Master's and PhD degree in Computer Science at the Chair for Computer Aided Medical ProceduresFakultät für InformatikTechnische Universität München. Afterwards, he led a group of scientists at the Technische Universität München to work on histology reconstruction, with which the original idea to microDimensions was born. His knowledge in image registration, segmentation, and visualization guarantees the high-tech standard of products developed by microDimensions.

Marco Feuerstein

Dr. Marco Feuerstein (COO)
is co-founder of microDimensions. He holds an MSc and a PhD in Computer Science from Technische Universität München and was awarded multiple prestigious scholarships in Singapore, Taiwan, Japan, and Germany. He worked at several German and Singaporean high-tech companies such as BMW and Siemens. During his 2-year postdoctoral fellowship in Japan he was successfully leading a team of researchers working on different aspects of bronchoscopy. He has 13 years of programming experience and 8 years of experience in medical image processing and computer aided diagnosis and surgery. He authored and coauthored more than 35 international peer-reviewed papers and several patent applications.

Hauke Heibel

Dr. Hauke Heibel (CTO)
is co-founder of microDimensions. He was senior R&D engineer at metaio GmbH München for more than 2 years, working on software design, managing projects with close customer contact, and leading a team of developers. He has 15 years of programming experience, actively participating in various open source software projects, and 8 years of experience in medical image processing and computer vision. He studied Computer Science at Technische Universität München and defended his PhD in May 2011.

Stephanie Kapitza

Dr. Stephanie Kapitza, MBR (CFO)
is responsible for finance and administration. After apprenticeship training and work experience with Dresdner Bank AG, she received Masters degrees in Human Resource Education & Management as well as Business Research from Georg-August-Universität Göttingen and from Ludwig-Maximilians-Universität München. Accompanying her studies she gained working experience within pharmaceutical industry. While finishing her subsequent PhD thesis at LMU she designed and coached Business Planning courses at the LMU’s Munich School of Management.

Andreas Keil

Dr. Andreas Keil (VP Business Development)
is responsible for identifying products and markets for the company by communicating and coordinating with customers and other stakeholders. Prior to joining microDimensions, Andreas was a post-doctoral fellow in the Radiological Sciences Lab at Stanford University's School of Medicine. He has worked as an intern and research assistant at several divisions of Siemens in Germany and the US as well as France's prestigious National Institute for Research in Computer Science and Control. Andreas holds a master's degree in Mathematics and a PhD in Computer Science from Technische Universität München.

Advisory Board

Christian Hilz

Dr. Christian Hilz (Chairman)
is Managing Director at TREND-STORE shop creation GmbH. He was CFO of Proteros biostructures GmbH and AutoVision GmbH, a 100% subsidiary of Volkswagen AG, as well as a position as Managing Director at AutoVision Belgium. He also held the position of Managing Director at TUM Tech GmbH, a consulting company focused on technology transfer from Technische Universität München. He received a degree and a subsequent PhD in Business Administration from Ludwig-Maximilians-Universität München.

Kerstin Amann

Prof. Dr. med. Kerstin Amann
is head of the Nephropathology at Friedrich-Alexander-Universität Erlangen-Nürnberg. She studied Medicine at the Ruprecht-Karls-Universität in Heidelberg and was awarded the Bernd-Tersteegen-Preis, the Dieter-Klaus-Förderpreis, the Franz-Volhard-Preis, as well as several congress awards. She gave numerous invited talks at international congresses, such as International Society of Nephrology, European Renal Association, European Society of Cardiology, European Peritoneal Dialysis Society, and European Society of Artificial Organs. Mrs. Amann is member of several international congress advisory committees and of the management team of the Deutsche Gesellschaft für Nephrologie.

Dirk Kreder

Dr. Dirk Kreder, MBA
is founder and CEO of anteris medical GmbH. Anteris develops medical devices for a broad customer portfolio in the biopharma and medical device industries, and brings them to regulatory clearance in Europe and the US. Before building his own company, Dirk held positions of increasing responsibility with pharma and biopharma companies in the US, Switzerland, and Germany, amongst them Novartis, Roche, and Abgenix (now Amgen).  Dirk holds a Ph.D. in Immunology and Molecular Biology from University of Stuttgart, an International Executive MBA from the Euro*MBA Consortium, and received post-graduate training certificates from Harvard Business School and the University of California Santa Cruz.

Adriaan Hart de Ruijter

Dr. Adriaan Hart de Ruijter, MBA
is managing director of Cascara Ventures, an early stage life sciences venture fund. He has over twenty-seven years of experience in the life science industry. He founded MSOURCE, the European contract research organization in 1994, which he sold to TÜV SÜD in 2008 (now CROMsource). Since then he ventured into medical data, imaging, oncology and several other therapeutic areas through partnerships and venture capital, building new companies and realizing exits. Adriaan Hart de Ruijter is a specialist in pharmaceutical medicine and holds an MD degree from Leiden University and an MBA from the Rotterdam School of Management.

Scientific Mentor

Nassir Navab

Prof. Dr. Nassir Navab
founded the Chair for Computer Aided Medical Procedures & Augmented RealityTechnische Universität München, which is considered one of the most innovative institutions of its kind in Germany. He holds a secondary appointment at the School of Medicine. He is also co-founder and advisory board member of SurgicEye GmbH. He studied Mathematics and Physics at the Université Nice-Sofia Antipolis, France, and received his PhD at INRIA, France. After spending the following two years as postdoctoral fellow at Massachusetts Institute of Technology in USA, he worked for Siemens Corporate Research in Princeton in various executive scientific positions in medical imaging divisions, where he was also awarded "Inventor of the Year" (>300 international peer-reviewed papers and >40 patent families).